Search
Close this search box.

New Publication from Christopher Armstrong & Colleagues!

Today, we are excited to share a new publication from Christopher Armstrong, PhD, and colleagues: Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies.” This comprehensive review is proudly supported by OMF.

 

 

Headshot of Chris Armstrong smiling.From the Desk of Christopher Armstrong, PhD, 

Director of the Melbourne ME/CFS Collaboration

 

I am proud to present our review paper in Cell Trends in Molecular Medicine, which delves into the recent research world of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and its potential insights into understanding Long COVID (LC).

 

To complete this review, we assessed over 500 ME/CFS reviews and research articles released over the past five years and there were approximately 300 research papers with appropriate sample sizes that we used to formulate this review. We sub-categorized the publications into research areas and ultimately chose five areas to focus on within the review. This choice was based on their relevance to LC and the breadth of research. 

 

The major areas covered include:

  • Metabolic abnormalities
  • Immune dysfunction
  • Vascular pathologies
  • Central nervous system dysfunction
  • Gut dysbiosis

Although we couldn’t include all the papers we reviewed, it was heartening to see the quality and quantity of research in ME/CFS over the past years. The field is rapidly expanding, with fresh research and new names emerging amidst the wealth of published articles.

 

As part of the review, we produced a simple cyclical model that brings the major research areas together to highlight that any combination of these areas can and likely do interact to create an altered physiological state underpinning the disease. Individual patients are unlikely to present the full array anomalies but likely experience enough to sustain a cycle or loop, thereby creating a model that can account for the heterogeneity of the disease. 

 

Our simple model, though basic in nature, could potentially provide a valuable perspective for understanding the complexities of both ME/CFS and Long COVID. The paper underscores the shared clinical similarities between the two conditions, offering a unique perspective on disease pathologies and their interconnected influence.

 

Read the full review! 

 


 

Help support important research initiatives like this!

Your donations of any amount advance our mission to end 

ME/CFS and Long COVID.

 

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669